scispace - formally typeset
P

Phillip I. Tarr

Researcher at Washington University in St. Louis

Publications -  308
Citations -  24700

Phillip I. Tarr is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Escherichia coli & Shiga toxin. The author has an hindex of 76, co-authored 292 publications receiving 22052 citations. Previous affiliations of Phillip I. Tarr include Dalhousie University & Washington Department of Social and Health Services.

Papers
More filters
Journal ArticleDOI

Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome

TL;DR: Management of HUS remains supportive; there are no specific therapies to ameliorate the course, and the best way to prevent HUS is to prevent primary infection with Shiga-toxin-producing bacteria.
Journal ArticleDOI

The Risk of the Hemolytic–Uremic Syndrome after Antibiotic Treatment of Escherichia coli O157:H7 Infections

TL;DR: In this paper, a prospective cohort study of 71 children younger than 10 years of age who had diarrhea caused by E. coli O157:H7 was conducted to assess whether antibiotic treatment in these children affects the risk of the hemolytic-uremic syndrome and to assess the influence of confounding factors on this outcome.
Journal ArticleDOI

Enterohaemorrhagic Escherichia coli in human medicine

TL;DR: This review will focus on the microbiology, epidemiology, and pathophysiology of EHEC-associated diseases, and illustrate future challenges and opportunities for their control.